Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Rheumatoid Arthritis; Rheumatoid Arthritis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00688103
What this trial is testing

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan

Who this might be right for
Rheumatoid Arthritis
Japan Biological Agent Study Integrated Consortium 151
Testing effectiveness (Phase 2)Study completedNCT00550446
What this trial is testing

Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 386
Post-approval studies (Phase 4)Ended earlyNCT00706797
What this trial is testing

Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects

Who this might be right for
Rheumatoid Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer 141
Large-scale testing (Phase 3)Study completedNCT00750880
What this trial is testing

An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,681
Testing effectiveness (Phase 2)Study completedNCT04634253
What this trial is testing

LY3462817 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 98
Large-scale testing (Phase 3)UnknownNCT03535402
What this trial is testing

Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics

Who this might be right for
Rheumatoid Arthritis
Gaylis, Norman B., M.D. 20
Testing effectiveness (Phase 2)Study completedNCT01185353
What this trial is testing

A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy

Who this might be right for
Arthritis, Rheumatoid
Eli Lilly and Company 301
Testing effectiveness (Phase 2)Study completedNCT01526057
What this trial is testing

A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)

Who this might be right for
Rheumatoid Arthritis
Pfizer 220
Not applicableUnknownNCT05938244
What this trial is testing

Cardiac and Pulmonary Assessment in Egyptian Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Assiut University 34
Testing effectiveness (Phase 2)Study completedNCT00928512
What this trial is testing

Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 237
Testing effectiveness (Phase 2)Study completedNCT01181050
What this trial is testing

Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)

Who this might be right for
InflammationRheumatoid Arthritis
Janssen Research & Development, LLC 63
Large-scale testing (Phase 3)Ended earlyNCT02647762
What this trial is testing

CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Can-Fite BioPharma 244
Not applicableStudy completedNCT04356183
What this trial is testing

Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular Risk

Who this might be right for
Rheumatoid Arthritis
Duke University 24
Large-scale testing (Phase 3)Study completedNCT00753454
What this trial is testing

Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 168
Testing effectiveness (Phase 2)UnknownNCT04120831
What this trial is testing

TOLERA: Tolerance Enhancement in RA

Who this might be right for
Rheumatoid Arthritis
University of Erlangen-Nürnberg Medical School 20
Large-scale testing (Phase 3)Study completedNCT01606761
What this trial is testing

CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 878
Testing effectiveness (Phase 2)Study completedNCT00147966
What this trial is testing

Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)

Who this might be right for
Rheumatoid Arthritis
University of California, San Diego 24
Testing effectiveness (Phase 2)Looking for participantsNCT07409103
What this trial is testing

Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

Who this might be right for
Active Rheumatoid Arthritis
Elevara Medicines Limited 180
Early research (Phase 1)Study completedNCT01123070
What this trial is testing

TL011 in Severe, Active Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Teva Pharmaceutical Industries, Ltd. 54
Testing effectiveness (Phase 2)Ended earlyNCT01569152
What this trial is testing

Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)

Who this might be right for
Rheumatoid Arthritis (RA)
Merck Sharp & Dohme LLC 82
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation